Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2655${count})

  • Research Grant, 2024
    SUPPLEMENT: Development of a Protein Biomarker Panel to Measure Parkinson’s Disease Activity and Progression

    Study Rationale: Managing and treating Parkinson’s is extremely challenging without the right tools and insights. According to the Michael J. Fox Foundation, “the need for objective Parkinson’s...

  • De-risking Therapeutic Development for NOD2

    Summary of Target and Rationale for Funding: NOD2 is a signaling protein that plays a central role in regulating immune and inflammatory pathways. Preliminary genetic data suggest a potential link...

  • T2T Validation - NOD2, 2025
    Inflammatory and Regulatory Functions of NOD2 in the Setting of Parkinson’s Disease

    Study Rationale: NOD2 is a signaling protein which has been found to be more abundant and more active in brain tissues of patients with Parkinson’s disease. Certain changes in the sequence encoding...

  • Summer 2021 RFP: Expanding Biological Understanding of PD, 2025
    SUPPLEMENT: Urinary Biomarkers of Retromer Dysfunction in Parkinson’s Disease

    Study Rationale: “Retromer” is a molecular machine that regulates the trafficking of many proteins within a cell. While a dysfunction of Retromer is now known to be central in triggering and driving...

  • T2T Validation - Endolysosomal Targets, 2025
    In Vivo Efficacy of a TRPML1 Activating Compound in Alpha-synuclein PD Pre-clinical Models

    Study Rationale: Many genes harboring mutations that increase the risk for developing Parkinson’s disease (PD) are associated with the cell’s recycling center, the lysosome. Compounds activating the...

  • T2T Validation - Endolysosomal Targets, 2025
    Development of in Vivo Biomarkers for TRPML1 Target Engagement and Analysis of Therapeutics

    Study Rationale: The appropriate regulation of proteins and lipids within neurons is critical for human health. Lysosomes are specialized structures within cells that are responsible for the removal...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.